Glaxosmithkline Share Price in 1995: Chart, Monthly Trends, & Analysis

How did Glaxosmithkline shares perform in 1995?

Let's find out!

Glaxosmithkline share price in 1995 was ₹189 Its price on 1st January 1995 was ₹255, and by 31st December 1995 it moved to ₹189, giving a negative return of -25.89% for the year.

Glaxosmithkline Share Open, High, Low, and Close prices for the Year 1995 are as follows:

Open	High	Low	Close
₹255	₹270	₹165	₹189
1st Jan 1995	Occured in Jan 1995	Occured in Nov 1995	31st Dec 1995

This page will help you understand how Glaxosmithkline performed in 1995. Let's get started.

For complete insights into Glaxosmithkline’s incredible stock price performance and growth, see: Glaxosmithkline Historical Share Price Data from its IPO to 2025

Table: Glaxosmithkline Share Monthly Close, Low, High Prices for 1995

Month	Glaxosmithkline	Change%	↑High - ↓Low
Jan	₹242.5	-	↑ ₹270 ↓ ₹220
Feb	₹230	-5.2%	↑ ₹250 ↓ ₹215
Mar	₹220	-4.4%	↑ ₹240 ↓ ₹210
Apr	₹195	-11.4%	↑ ₹230 ↓ ₹185
May	₹195	-	↑ ₹200 ↓ ₹178
Jun	₹176	-9.8%	↑ ₹200 ↓ ₹172
Jul	₹199	13%	↑ ₹209 ↓ ₹169
Aug	₹177	-11.1%	↑ ₹200 ↓ ₹175
Sep	₹197	11.2%	↑ ₹200 ↓ ₹175
Oct	₹200	1.5%	↑ ₹206 ↓ ₹192
Nov	₹175	-12.5%	↑ ₹202 ↓ ₹165
Dec	₹189	8%	↑ ₹194 ↓ ₹175

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Glaxosmithkline in 1995?

In 1995, the opening price of Glaxosmithkline share was ₹255.00. Today, the price stands at ₹3,309, reflecting a growth of 1,197.64%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 1995 would have become ₹1.29 Lakh by 2025. This represents a CAGR of 8.92%.

---

You might also like to check: Glaxosmithkline Stock Price in 1994 or Glaxosmithkline Stock Price in 1996

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.